BrightHeart is a France-based startup that is revolutionizing prenatal ultrasound screening through the integration of AI. Its slogan "Advancing prenatal ultrasound screening with AI" encapsulates the company's mission to ensure that every fetal ultrasound screening exam is conducted with the utmost accuracy, thereby ensuring the highest possible quality of care for both the mother and the baby.
Founded in 2020, BrightHeart operates within the Health Care and Medical Devices industries, focusing on bringing cutting-edge technology to the field of prenatal care.
The company recently secured a significant boost with a €2.00MSeed Round investment on 31 May 2023. This investment was led by Sofinnova Partners, signifying strong support and confidence from this reputable investor in BrightHeart's vision and potential.
With its innovative approach and recent investment, BrightHeart is poised to make meaningful contributions to the improvement of prenatal care, leveraging AI to enhance the accuracy and efficacy of fetal ultrasound screenings.